Moderna and Merck Announce Positive Skin Cancer Vaccine Trial Results
Moderna and Merck have announced positive results from a clinical trial for an mRNA-based vaccine designed to prevent the recurrence of melanoma, a type of skin cancer. This breakthrough has significantly boosted Moderna's stock and is seen as a major step towards new cancer treatments.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (92/100)Sources
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
By Rebecca Robbins
Read full article →Moderna pins hopes on mRNA ‘game-changer’ for cancer vaccines
Technology behind blockbuster Covid-19 jabs is now yielding promising results in oncology treatment
Read full article →New mRNA vaccine could reduce the recurrence and spread of skin cancer
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
By Leila Fadel
Read full article →Landmark vaccine stops cancer returning in trial - The Times
Landmark vaccine stops cancer returning in trial The Times
Read full article →Moderna and Merck's cancer vaccine raises new treatment hope
Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna's shares surging as much as 160%.
Read full article →‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.
By Michael Erman, Julie Steenhuysen
Read full article →Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines
Read full article →The Irish Independent’s View: No room for complacency on skin cancer prevention and detection
By Editorial
Read full article →Moderna, Merck breakthrough could usher in wave of cancer vaccines
The treatment involves pairing Merck's immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.
Read full article →Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead
Read full article →Moderna, Merck breakthrough could usher in wave of cancer vaccines
Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, which revs up the immune system, personalized cancer vaccines train the immune system to specifically target mutations found only on a person's tumor
By Reuters
Read full article →Vaccine breakthrough stops cancer returning in trial
A new personalised vaccine, given in combination with a drug, has prevented skin cancer from returning in patients during a trial, marking a potentially watershed moment in cancer treatment.
By Abubakar Ibrahim
Read full article →
